Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Equity (2023 - 2025)

Mangoceuticals' Return on Equity history spans 3 years, with the latest figure at 1.13% for Q3 2025.

  • For Q3 2025, Return on Equity fell 46.0% year-over-year to 1.13%; the TTM value through Sep 2025 reached 1.13%, down 46.0%, while the annual FY2024 figure was 1.18%, N/A changed from the prior year.
  • Return on Equity for Q3 2025 was 1.13% at Mangoceuticals, down from 0.72% in the prior quarter.
  • Across five years, Return on Equity topped out at 98.19% in Q1 2024 and bottomed at 8.65% in Q4 2023.
  • The 3-year median for Return on Equity is 0.7% (2024), against an average of 10.54%.
  • The largest annual shift saw Return on Equity skyrocketed 802bps in 2024 before it tumbled -9884bps in 2025.
  • A 3-year view of Return on Equity shows it stood at 8.65% in 2023, then soared by 93bps to 0.63% in 2024, then plummeted by -81bps to 1.13% in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Return on Equity are 1.13% (Q3 2025), 0.72% (Q2 2025), and 0.65% (Q1 2025).